Michael Egholm
Vorstandsvorsitzender bei STANDARD BIOTOOLS INC.
Vermögen: 4 Mio $ am 31.05.2024
Profil
Michael Egholm was the founder of Danaher Corp.
(founded in 2017) where he held the title of Chief Technology Officer-Danaher Life Sciences from 2017 to 2021.
He is currently the President, Chief Executive Officer & Director at Standard BioTools, Inc. (since 2022) and the President, CEO, Secretary, Treasurer & Director at SomaLogic, Inc. (since 2024).
He is also a Director at Abbratech, Inc. and a Member of the Royal Danish Academy of Sciences & Letters.
In his former positions, he served as an Independent Director at IsoPlexis Corp.
(2018-2022), President-Biopharmaceuticals at Pall Corp.
(2014-2017), Vice President-Research at Molecular Staging, Inc., and Chief Technology Officer at 454 Life Sciences Corp.
He also held the position of Chief Technology Officer at Roche Applied Science from 2008 to 2010.
Dr. Egholm obtained a doctorate degree from the University of Copenhagen.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
STANDARD BIOTOOLS INC.
0,40% | 20.05.2024 | 1 531 592 ( 0,40% ) | 4 Mio $ | 31.05.2024 |
Aktive Positionen von Michael Egholm
| Unternehmen | Position | Beginn |
|---|---|---|
| STANDARD BIOTOOLS INC. | Vorstandsvorsitzender | 04.04.2022 |
| STANDARD BIOTOOLS INC. | Vorstandsvorsitzender | 05.01.2024 |
Abbratech, Inc.
 Abbratech, Inc. BiotechnologyHealth Technology Abbratech, Inc. is a biotechnology company that focuses on precision antibodies. Abbratech is based in Branford, CT. The company offers services such as antigen and project design, recombinant antibody development, antibody optimization, and antibody production. Abbratech uses the best available in vivo and in vitro methods for antibody discovery and applies knowledge gained from the past 15 years of human genome sequencing and antibody engineering to produce high affinity and highly specific recombinant antibodies. The company was founded in 2020 by Michael P. Weiner, who has been the CEO since then. | Direktor/Vorstandsmitglied | - |
| Royal Danish Academy of Sciences & Letters | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Michael Egholm
| Unternehmen | Position | Ende |
|---|---|---|
| ISOPLEXIS CORPORATION | Direktor/Vorstandsmitglied | 22.08.2022 |
| DANAHER CORPORATION | Gründer | 01.09.2021 |
| PALL CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 10.09.2014 |
Roche Applied Science
 Roche Applied Science Miscellaneous Commercial ServicesCommercial Services Roche Applied Science operates as a biotechnology firm focused on researches in molecular diagnostics. The company is headquartered in Indiana. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2010 |
454 Life Sciences Corp.
 454 Life Sciences Corp. Medical/Nursing ServicesHealth Services 454 Life Sciences Corp. engages in the provision of medical testing services to determine the nucleotide sequence of whole genomes. The company was founded by Jonathan M. Rothberg in 2000 and is headquartered in Branford, CT. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Michael Egholm
| University of Copenhagen | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| DANAHER CORPORATION | Health Technology |
| STANDARD BIOTOOLS INC. | Health Technology |
| STANDARD BIOTOOLS INC. | Commercial Services |
| Private Unternehmen | 7 |
|---|---|
Pall Corp.
 Pall Corp. Medical SpecialtiesHealth Technology Pall Corp. designs, manufactures, and markets filtration and separation equipment. Its products are used to remove solid, liquid, and gaseous contaminants from a variety of liquids and gases. The firm has Life Sciences and Industrial segments. The Life Sciences segment focuses on developing, manufacturing, and selling products to customers in the medical, biopharmaceuticals, and food and beverage markets. The Industrial segment focuses on developing, manufacturing and selling products to customers in the process technologies, aerospace, and microelectronics markets. The company was founded by David B. Pall on July 31, 1946 and is headquartered in Port Washington, NY. | Health Technology |
IsoPlexis Corp.
 IsoPlexis Corp. Packaged SoftwareTechnology Services IsoPlexis Corp. engages in the development of curative medicines and personalized therapeutics. Its single cell proteomics platform, which includes instruments, chip consumables and software, provides an end-to-end solution to reveal a more complete view of protein function at an individual cellular level. The company was founded by Sean Mackay, Rong Fan, and Kara K. Brower in March 2013 and is headquartered in Branford, CT. | Technology Services |
Molecular Staging, Inc.
 Molecular Staging, Inc. Medical SpecialtiesHealth Technology Molecular Staging, Inc. (MSI) developed products for the detection & measurement of proteins and nucleic acids. The company's amplification technologies included products & services that identify individual and multiplexed sets of biomarkers & a method of generating DNA from a few cells. MSI enabled transformational products and services across multiple health care markets. The company was founded in 1998 and was located in New Haven, CT. | Health Technology |
454 Life Sciences Corp.
454 Life Sciences Corp. Medical/Nursing ServicesHealth Services 454 Life Sciences Corp. engages in the provision of medical testing services to determine the nucleotide sequence of whole genomes. The company was founded by Jonathan M. Rothberg in 2000 and is headquartered in Branford, CT. | Health Services |
Roche Applied Science
Roche Applied Science Miscellaneous Commercial ServicesCommercial Services Roche Applied Science operates as a biotechnology firm focused on researches in molecular diagnostics. The company is headquartered in Indiana. | Commercial Services |
| Royal Danish Academy of Sciences & Letters | |
Abbratech, Inc.
Abbratech, Inc. BiotechnologyHealth Technology Abbratech, Inc. is a biotechnology company that focuses on precision antibodies. Abbratech is based in Branford, CT. The company offers services such as antigen and project design, recombinant antibody development, antibody optimization, and antibody production. Abbratech uses the best available in vivo and in vitro methods for antibody discovery and applies knowledge gained from the past 15 years of human genome sequencing and antibody engineering to produce high affinity and highly specific recombinant antibodies. The company was founded in 2020 by Michael P. Weiner, who has been the CEO since then. | Health Technology |
